The effect of intralesional injection of glucantime with low-level laser therapy in the treatment of acute cutaneous leishmaniasis

Not Applicable

Recruiting

• Conditions: Acute cutaneous leishmaniasis.; Cutaneous leishmaniasis; B55.1

• Registration Number: IRCT20200825048515N14
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Proven diagnosis of acute rural cutaneous leishmaniasis by testing
The number of lesions of less than 4
The disease course of fewer than 100 days
Lesion size of less than 3 cm
No lesion on the eyelid (less than 2 cm from the eyelid)
Aged over 5 years old
No lesion on cartilage or joint and face

Exclusion Criteria

Presence of sporotrichoid lesions or satellite lesions
Taking immunosuppressive drugs during the last 6 months
The history of receiving topical or systemic anti-leishmaniasis treatment in the past month
Lack of consent to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
esion healing. Timepoint: The first to twelfth weeks from the beginning of the intervention. Method of measurement: Observation.;Lesion area. Timepoint: The first to twelfth weeks from the beginning of the intervention. Method of measurement: Ruler.

Secondary Outcome Measures

Name	Time	Method
Recurrence of the lesion. Timepoint: Three months and six months after the intervention. Method of measurement: Observation.